June 18 (Reuters) - A new panel of U.S. vaccine advisers

appointed by Health Secretary Robert F. Kennedy Jr. will vote on

flu shots that contain a mercury-based preservative called

thimerosal and discuss recommendations for measles shot at an

upcoming meeting.

The advisers to the Centers for Disease Control and

Prevention will also vote on who should receive the shots for

respiratory syncytial virus and influenza at the meeting

scheduled for June 25 and 26, according to a draft agenda posted

on CDC's website.

Experts will discuss proposed recommendations whether a shot

to prevent measles, mumps, rubella, and varicella (MMRV) should

be given to children under 5 years of age.

The agenda did not specify who will be presenting on MMRV or

thimerasol at the meeting.

Thimerosal has been used for decades in the United States in

vials for medicines and vaccines that containing more than one

dose, according to CDC.